Evidence map›Paper›PMID 35549822›Full record

ArticleBioengineered2022

IFC-305 attenuates renal ischemia-reperfusion injury by promoting the production of hydrogen sulfide (H

Jie Jiang, Chuling Wen, Yi Li, Guohui Liu, Zijun Chen, Dongwen Zheng

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jie JiangNephrology Department, Dongguan People's Hospital Affiliated to Southern Medical University, Dongguan, China.
Chuling WenNephrology Department, Dongguan People's Hospital Affiliated to Southern Medical University, Dongguan, China.
Yi LiNephrology Department, Dongguan People's Hospital Affiliated to Southern Medical University, Dongguan, China.
Guohui LiuNephrology Department, Dongguan People's Hospital Affiliated to Southern Medical University, Dongguan, China.
Zijun ChenNephrology Department, Dongguan People's Hospital Affiliated to Southern Medical University, Dongguan, China.
Dongwen ZhengNephrology Department, Dongguan People's Hospital Affiliated to Southern Medical University, Dongguan, China.ORCID 0000-0003-4532-8301
Dongguan People’s Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal ischemia-reperfusion (I/R) injury is characterized by elevated expression of homocysteine and decreased production of hydrogen sulfide (H

Indexed as

Hydrogen SulfideReperfusion InjuryAdenosineAnimalsCystathionine gamma-LyaseDNA MethylationHomocysteineKidneyRatsSuperoxidesAdenosineadenosine 2-aminosuccinic acid-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diolCystathionine gamma-LyaseHomocysteineHydrogen SulfideSuperoxidesCSEH2ShomocysteineIFC-305oxidative stressRenal I/R

Identifiers

PMID35549822
PMCPMC9275864
OpenAlexW4280556286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.